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The COVID-19 pandemic is not only a challenge to public health
structures and economies but also a touchstone for international soli-
darity. Due to the implicit cross-border nature of the outbreak, the
international health imperative of “Leaving No One Behind” has
become more categorical than ever before. Central Asia, however,
still seems to be a white spot on the map of Coronavirus response
activities, with sparse international media coverage and few, if any,
scientific publications. Geographically and culturally remote, the five
countries Kazakhstan, Kirgizstan, Tajikistan, Turkmenistan, and
Uzbekistan of ex-Soviet Asia have often been overlooked and are
indifferently considered to be among the most repressive and self-
isolating countries in the world. While the pandemic ruthlessly
unveiled many weaknesses of public health systems globally, it also
disclosed hitherto unrecognised positive changes in foreign policy,
including new affirmative approaches to international cooperation in
COVID-19 outbreak response. With more than 33.5 million people,
Uzbekistan is the region's most populous state and one example of a
country in transition. Since the election of Shavkat Mirziyoyev as
president in December 2016, it signalled not only its intention to
improve relations with its neighbouring countries, but also a commit-
ment to open Uzbekistan to the international community.
Following an invitation from the Ministry of Health in Tashkent, a
team of experts led by the Robert Koch Institute from Berlin and com-
plemented by experts from the WHO Regional Office for Europe vis-
ited Uzbekistan on August 2128, 2020. As a lower-middle-income
economy with a relatively young population (median age in Uzbeki-
stan is 27.8 years), the country has been strongly affected by the pan-
demic, with 70,921 reported cases and 601 reported deaths as of* Corresponding author.
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tions in April 2020, a second, more severe wave commenced at the
end of May 2020. Like most countries worldwide, the health care sys-
tem was initially overwhelmed.
The need to provide a solution for a large number of patients led
to the construction of a 3139-bed stationary COVID-19 hospital in
Tashkent, following the example of the Chinese emergency specialty
hospitals. In the Republic of Karakalpakstan, Samarkand, and Naman-
gan, rapid response capabilities and critical care services were suc-
cessfully established in sport halls within a week. The facility in
Samarkand, which our mission has visited, includes an ICU with
approximately 100 beds, a small PCR laboratory, and a triage centre.
Modular infectious diseases hospitals with the total number of
23,168 beds and triage and treatment centres with the total number
of 8,994 beds have been established in all regions of the country.
Nationwide, the number of COVID-19 laboratories was increased
from 3 to 111 with a capacity of 35,000 tests per day. These laborato-
ries are equipped with 150 sets of laboratory equipment for conduct-
ing PCR tests and are staffed with 510 laboratory workers, including
doctors and laboratory technicians.
A second lockdown and campaigns to promote physical distancing
and wearing of masks contributed to a decrease in cases since the
beginning of August. However, challenges exist with regard to inte-
grated surveillance and limited staff capacities in all areas of response.
To give a situation overview and inform decision-making during
outbreak, the country presents a functional basic surveillance system
that provides daily regional data published as a dashboard. The WHO
regularly distributes COVID-19 situation reports for Uzbekistan. In
addition, there is an ongoing self-assessment for the Joint External
Evaluation (JEE) of International Health Regulations (2005) imple-
mentation in the country.
Since the beginning of the pandemic, the government of Uzbekistan
has demonstrated its commitment to international cooperation and
exchange of experience on thematters of outbreak response and patient
treatment. Missions from Germany, Russia, South Korea, and Turkey
have visited the country. The initial assessment mission of the Robert
Koch Institute was followed by the second clinical mission on October
29November 12, 2020 to support the healthcare workers in COVID-19
treatment centres across the country. Furthermore, Uzbekistan joined
as a partner in a forthcoming international serological study on theC-ND IGO license (http://creativecommons.org/licenses/by-nc-nd/3.0/igo/)
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eral clinical training programmes are in development together with
German colleagues, including the strengthening of intensive care capac-
ity for treatment of COVID-19 patients as well as the telemedicine proj-
ect between Germany and Uzbekistan.
During both RKI missions, the teams were invited to move freely
between cities and within institutes and facilities. Many open and
critical discussions with Uzbek colleagues from all levels of the
healthcare system informed the team about the current status of
response and provided an evidence base for recommendations given
directly to the Minister of Health. Uzbekistan’s new era of openness
puts a spotlight on the self-conception and the integrity of suprana-
tional organisations and western states as the main propagators of
international solidarity. Corresponding commitments and initiatives
are incremental, and deeds should follow words, e.g., when it comes
to equal distribution of vaccines or access to research activities  not
just for Uzbekistan, but for all countries that have freely chosen to be
part of the international community.
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